Outcomes in patients with heart failure with regard to statin
therapy by Amina Godinjak et al.
2019;14(9-10):222.
6th Cardiology Highlights
The European Society of Cardiology Update Meeting 
October 17-20, 2019 | Dubrovnik, Croatia
Outcomes in patients with heart failure with regard to statin 
therapy










1Eurofarm Centar Medical 
Clinic, Sarajevo, Bosnia and 
Herzegovina
2Clinical Center University of 
Sarajevo, Sarajevo, Bosnia 
and Herzegovina
3General Hospital Sarajevo, 
Sarajevo, Bosnia and 
Herzegovina
KeYWORdS: heart failure, statin therapy, outcome.
citAtiON: Cardiol Croat. 2019;14(9-10):222. | https://doi.org/10.15836/ccar2019.222
*AddReSS fOR cORReSpONdeNce: Amina Godinjak, Fra Anđela Zvizdovića 1, 71000 Sarajevo, Bosnia and Herze-
govina. / Phone: +38761187010 / Email: aminagodinjak@gmail.com
ORcid: Amina Godinjak, https://orcid.org/0000-0002-3697-8006 • Miralem Dešević, https://orcid.org/0000-0001-8760-6192
Amer Iglica, https://orcid.org/0000-0002-4677-8489 • Adis Kukuljac, https://orcid.org/0000-0002-4900-5094
LiteRAtURe
1. Alehagen U, Benson L, Edner M, Dahlström U, Lund LH. Association between use of statins and outcomes in heart failure with reduced ejection 
fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry. Circ Heart Fail. 2015 
Mar;8(2):252-60. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001730
2. Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattar N, et al.The effect of statin therapy on heart failure events: a collaborative meta-
analysis of unpublished data from major randomized trials. Eur Heart J. 2015 Jun 21;36(24):1536-46. https://doi.org/10.1093/eurheartj/ehv072
Objective: The aim of this study was to investigate whether statin therapy influenced outcomes in 
patients with acute heart failure (HF).1,2 
Patients and Methods: Eighty five patients with diagnosis of HF were included in the study. For each 
patient the following data were obtained: gender, age, comorbidities and medications. New York Heart 
association (NYHA) class for heart failure was determined by physician evaluation and left ventricle 
ejection fraction (LVEF) was determined by echocardiography. Outcome points were: hospitalization, 
in-hospital death, mortality after 6 months, 1 year and 2 years. All-cause mortality included cardiovas-
cular events or worsening heart failure. 
Results: Mortality after 6 months, 1 year and 2 years was the most frequent in patients without statin 
therapy with a statistically significant difference (p = 0.001). Progression of HF accounted for 31.7% of 
mortality in patients without statin therapy. 
Conclusion: Statin therapy is associated with substantially better long-term outcomes in patients with 
HF. 
